التفاصيل البيبلوغرافية
العنوان: |
1088MO A phase II study of neoadjuvant cemiplimab for stage II to IV cutaneous squamous cell carcinoma (CSCC): One-year follow-up |
المؤلفون: |
Gross, N., Miller, D.M., Khushalani, N.I., Divi, V., Ruiz, E., Lipson, E.J., Meier, F., Su, Y.B., Swiecicki, P.L., Atlas, J.L., Geiger, J.L., Hauschild, A., Choe, J.H., Hughes, B.G.M., Yoo, S-Y., Mathias, M.D., Han, H., Fury, M.G., Rischin, D. |
المصدر: |
In Annals of Oncology October 2023 34 Supplement 2:S655-S655 |
قاعدة البيانات: |
ScienceDirect |